TNDM
Income statement / Annual
Last year (2023), Tandem Diabetes Care, Inc.'s total revenue was $747.72 M,
a decrease of 6.68% from the previous year.
In 2023, Tandem Diabetes Care, Inc.'s net income was -$222.61 M.
See Tandem Diabetes Care, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$747.72 M
|
$801.22 M
|
$702.80 M
|
$498.83 M
|
$362.31 M
|
$183.87 M
|
$107.60 M
|
$84.25 M
|
$72.85 M
|
$49.72 M
|
| Cost of Revenue |
$380.03 M |
$388.23 M |
$326.58 M |
$238.31 M |
$168.09 M |
$94.04 M |
$63.51 M |
$60.66 M |
$46.27 M |
$34.47 M |
| Gross Profit |
$367.69 M |
$412.99 M |
$376.22 M |
$260.52 M |
$194.21 M |
$89.82 M |
$44.09 M |
$23.59 M |
$26.58 M |
$15.25 M |
| Gross Profit Ratio |
0.49 |
0.52 |
0.54 |
0.52 |
0.54 |
0.49 |
0.41 |
0.28 |
0.36 |
0.31 |
| Research and Development
Expenses |
$169.67 M
|
$139.11 M
|
$92.05 M
|
$63.57 M
|
$45.20 M
|
$29.23 M
|
$20.66 M
|
$18.81 M
|
$16.96 M
|
$15.79 M
|
| General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$86.38 M
|
$82.83 M
|
$78.62 M
|
$75.12 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$1.00 M
|
$1.50 M
|
| Selling, General &
Administrative Expenses |
$352.50 M
|
$335.68 M
|
$261.51 M
|
$204.90 M
|
$165.74 M
|
$105.23 M
|
$86.38 M
|
$82.83 M
|
$78.62 M
|
$75.12 M
|
| Other Expenses |
$78.75 M |
-$4,000.00 |
$0.00 |
$0.00 |
-$7.88 M |
-$77.93 M |
-$10.08 M |
-$5.41 M |
-$3.40 M |
-$3.79 M |
| Operating Expenses |
$600.92 M |
$474.80 M |
$353.56 M |
$268.48 M |
$210.93 M |
$134.45 M |
$107.04 M |
$101.64 M |
$95.58 M |
$90.91 M |
| Cost And Expenses |
$980.95 M |
$863.03 M |
$680.15 M |
$506.79 M |
$379.03 M |
$228.50 M |
$170.55 M |
$162.30 M |
$141.85 M |
$125.39 M |
| Interest Income |
$22.86 M |
$6.06 M |
$674,000.00 |
$1.57 M |
$3.27 M |
$1.46 M |
$239,000.00 |
$296,000.00 |
$337,000.00 |
$112,000.00 |
| Interest Expense |
$9.88 M |
$4.31 M |
$4.31 M |
$12.15 M |
$78,000.00 |
$7.58 M |
$11.34 M |
$5.71 M |
$3.74 M |
$3.90 M |
| Depreciation &
Amortization |
$15.72 M
|
$14.33 M
|
$13.85 M
|
$10.45 M
|
$6.07 M
|
$5.82 M
|
$6.87 M
|
$5.49 M
|
$4.83 M
|
$4.39 M
|
| EBITDA |
-$194.66 M
|
-$72.31 M
|
$36.50 M
|
-$13.03 M
|
-$18.45 M
|
-$109.16 M
|
-$54.82 M
|
-$72.27 M
|
-$63.84 M
|
-$71.16 M
|
| EBITDA Ratio |
-0.26 |
-0.04 |
0.03 |
-0.02 |
-0.05 |
-0.24 |
-0.58 |
-0.93 |
-0.95 |
-1.52 |
| Operating Income Ratio
|
-0.31
|
-0.08
|
0.01
|
-0.02
|
-0.05
|
-0.24
|
-0.58
|
-0.93
|
-0.95
|
-1.52
|
| Total Other
Income/Expenses Net |
$12.98 M
|
-$4,000.00
|
-$6.75 M
|
-$28.33 M
|
-$7.88 M
|
-$77.93 M
|
-$10.08 M
|
-$5.41 M
|
-$3.40 M
|
-$3.79 M
|
| Income Before Tax |
-$220.25 M |
-$92.85 M |
$15.90 M |
-$36.28 M |
-$24.60 M |
-$122.56 M |
-$73.03 M |
-$83.46 M |
-$72.41 M |
-$79.45 M |
| Income Before Tax Ratio
|
-0.29
|
-0.12
|
0.02
|
-0.07
|
-0.07
|
-0.67
|
-0.68
|
-0.99
|
-0.99
|
-1.6
|
| Income Tax Expense |
$2.36 M |
$1.74 M |
$335,000.00 |
-$1.90 M |
$149,000.00 |
$51,000.00 |
$8,000.00 |
-$15,000.00 |
$10,000.00 |
$71,000.00 |
| Net Income |
-$222.61 M |
-$94.59 M |
$15.57 M |
-$34.38 M |
-$24.75 M |
-$122.61 M |
-$73.03 M |
-$83.45 M |
-$72.42 M |
-$79.52 M |
| Net Income Ratio |
-0.3 |
-0.12 |
0.02 |
-0.07 |
-0.07 |
-0.67 |
-0.68 |
-0.99 |
-0.99 |
-1.6 |
| EPS |
-3.43 |
-1.47 |
0.25 |
-0.56 |
-0.42 |
-2.55 |
-12.86 |
-27.3 |
-25.04 |
-34.17 |
| EPS Diluted |
-3.43 |
-1.47 |
0.24 |
-0.56 |
-0.42 |
-2.55 |
-12.86 |
-27.3 |
-25.04 |
-34.17 |
| Weighted Average Shares
Out |
$64.90 M
|
$64.15 M
|
$63.00 M
|
$60.99 M
|
$58.51 M
|
$48.13 M
|
$5.68 M
|
$3.06 M
|
$2.89 M
|
$2.33 M
|
| Weighted Average Shares
Out Diluted |
$64.97 M
|
$64.15 M
|
$64.35 M
|
$60.99 M
|
$58.51 M
|
$48.13 M
|
$5.68 M
|
$3.06 M
|
$2.89 M
|
$2.33 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
